NeoGenomics, Inc. Investing Cash Flow
NeoGenomics, Inc. (NEO) reported Investing Cash Flow of -$13.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-28
- NeoGenomics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$8.32M.
- NeoGenomics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$5.00M, a 240.45% decline year-over-year.
- NeoGenomics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$6.30M.
- NeoGenomics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$277.00K.
- NeoGenomics, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$12.34M, a 195.96% decline from fiscal 2024.
- NeoGenomics, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $12.86M, a 83.24% decline from fiscal 2023.
- NeoGenomics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $76.71M, a 14736.94% increase from fiscal 2022.
- NeoGenomics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $517.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$8.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | -$13.32M 10-Q · filed 2026-07-28 | -$19.62M derived: sum of 3 quarters · filed 2026-07-28 | -$19.90M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | -$5.00M 10-Q · filed 2026-04-28 | -$11.30M derived: sum of 2 quarters · filed 2026-04-28 | -$11.58M derived: sum of 3 quarters · filed 2026-04-28 | -$20.90M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | -$6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$6.58M derived: sum of 2 quarters · filed 2026-02-17 | -$15.90M derived: sum of 3 quarters · filed 2026-07-28 | -$12.34M 10-K · filed 2026-02-17 |
| 2025-09-30 | -$277.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | -$9.59M derived: sum of 2 quarters · filed 2026-07-28 | -$6.03M 10-Q · filed 2025-10-28 | -$11.50M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | -$9.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | -$5.75M 10-Q · filed 2026-07-28 | -$11.22M derived: sum of 3 quarters · filed 2026-07-28 | -$14.74M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $3.56M 10-Q · filed 2026-04-28 | -$1.91M derived: sum of 2 quarters · filed 2026-04-28 | -$5.42M derived: sum of 3 quarters · filed 2026-04-28 | $1.89M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | -$5.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$8.98M derived: sum of 2 quarters · filed 2026-02-17 | -$1.67M derived: sum of 3 quarters · filed 2026-02-17 | $12.86M 10-K · filed 2026-02-17 |
| 2024-09-30 | -$3.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $3.80M derived: sum of 2 quarters · filed 2025-10-28 | $18.32M 10-Q · filed 2025-10-28 | $35.52M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $7.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $21.84M 10-Q · filed 2025-07-29 | $39.03M derived: sum of 3 quarters · filed 2026-02-17 | $59.85M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $14.53M 10-Q · filed 2025-04-29 | $31.72M derived: sum of 2 quarters · filed 2026-02-17 | $52.54M derived: sum of 3 quarters · filed 2026-02-17 | $67.49M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $17.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $38.02M derived: sum of 2 quarters · filed 2026-02-17 | $52.97M derived: sum of 3 quarters · filed 2026-02-17 | $76.71M 10-K · filed 2026-02-17 |
| 2023-09-30 | $20.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $35.77M derived: sum of 2 quarters · filed 2024-11-05 | $59.51M 10-Q · filed 2024-11-05 | $58.45M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $14.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $38.69M 10-Q · filed 2024-07-30 | $37.63M derived: sum of 3 quarters · filed 2025-02-18 | $33.43M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $23.74M 10-Q · filed 2024-04-30 | $22.68M derived: sum of 2 quarters · filed 2025-02-18 | $18.48M derived: sum of 3 quarters · filed 2025-02-18 | $12.21M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | -$5.26M derived: sum of 2 quarters · filed 2025-02-18 | -$11.54M derived: sum of 3 quarters · filed 2025-02-18 | $517.00K 10-K · filed 2025-02-18 |
| 2022-09-30 | -$4.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$10.47M derived: sum of 2 quarters · filed 2023-11-06 | $1.58M 10-Q · filed 2023-11-06 | -$8.00M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | -$6.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $5.78M 10-Q · filed 2023-08-08 | -$3.81M derived: sum of 3 quarters · filed 2024-02-20 | -$18.49M derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | $12.05M 10-Q · filed 2023-05-09 | $2.47M derived: sum of 2 quarters · filed 2024-02-20 | -$12.22M derived: sum of 3 quarters · filed 2024-02-20 | -$465.63M derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | -$9.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$24.27M derived: sum of 2 quarters · filed 2024-02-20 | -$477.68M derived: sum of 3 quarters · filed 2024-02-20 | -$632.37M 10-K · filed 2024-02-20 |
| 2021-09-30 | -$14.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$468.10M derived: sum of 2 quarters · filed 2022-11-08 | -$622.78M 10-Q · filed 2022-11-08 | -$651.64M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | -$453.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$608.10M 10-Q · filed 2022-08-09 | -$636.95M derived: sum of 3 quarters · filed 2023-02-24 | -$707.67M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | -$154.69M 10-Q · filed 2022-05-09 | -$183.54M derived: sum of 2 quarters · filed 2023-02-24 | -$254.26M derived: sum of 3 quarters · filed 2023-02-24 | -$272.42M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | -$28.85M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$99.57M derived: sum of 2 quarters · filed 2023-02-24 | -$117.73M derived: sum of 3 quarters · filed 2023-02-24 | -$159.44M 10-K · filed 2023-02-24 |
| 2020-09-30 | -$70.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$88.88M derived: sum of 2 quarters · filed 2021-11-04 | -$130.59M 10-Q · filed 2021-11-04 | -$136.66M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | -$18.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$59.87M 10-Q · filed 2021-08-09 | -$65.95M derived: sum of 3 quarters · filed 2022-02-25 | -$73.26M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$41.71M 10-Q · filed 2021-05-06 | -$47.78M derived: sum of 2 quarters · filed 2022-02-25 | -$55.10M derived: sum of 3 quarters · filed 2022-02-25 | -$58.14M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | -$6.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$13.39M derived: sum of 2 quarters · filed 2022-02-25 | -$16.43M derived: sum of 3 quarters · filed 2022-02-25 | -$19.63M 10-K · filed 2022-02-25 |
| 2019-09-30 | -$7.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$10.36M derived: sum of 2 quarters · filed 2020-10-29 | -$13.55M 10-Q · filed 2020-10-29 | -$142.15M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$6.24M 10-Q · filed 2020-07-31 | -$134.83M derived: sum of 3 quarters · filed 2021-02-25 | -$136.98M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$3.20M 10-Q · filed 2020-04-29 | -$131.79M derived: sum of 2 quarters · filed 2021-02-25 | -$133.94M derived: sum of 3 quarters · filed 2021-02-25 | -$138.22M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$128.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$130.74M derived: sum of 2 quarters · filed 2021-02-25 | -$135.02M derived: sum of 3 quarters · filed 2021-02-25 | -$139.69M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$6.42M derived: sum of 2 quarters · filed 2019-11-13 | -$11.09M 10-Q · filed 2019-11-13 | -$14.61M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$4.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$8.94M 10-Q · filed 2019-08-07 | -$12.47M derived: sum of 3 quarters · filed 2020-02-28 | -$14.77M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | -$4.67M 10-Q · filed 2019-05-08 | -$8.19M derived: sum of 2 quarters · filed 2020-02-28 | -$10.49M derived: sum of 3 quarters · filed 2020-02-28 | -$15.35M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$3.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$5.83M derived: sum of 2 quarters · filed 2020-02-28 | -$10.68M derived: sum of 3 quarters · filed 2020-02-28 | -$13.69M 10-K · filed 2020-02-28 |
| 2017-09-30 | -$2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$7.16M derived: sum of 2 quarters · filed 2018-11-06 | -$10.17M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | -$4.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$7.86M 10-Q · filed 2018-08-06 | ||
| 2017-03-31 | -$3.01M 10-Q · filed 2018-05-08 | |||
| 2013-12-31 | -$525.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | -$1.40M derived: sum of 2 quarters · filed 2014-02-24 | -$1.77M derived: sum of 3 quarters · filed 2014-02-24 | -$2.01M 10-K · filed 2014-02-24 |
| 2013-09-30 | -$878.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$1.25M derived: sum of 2 quarters · filed 2013-10-30 | -$1.49M 10-Q · filed 2013-10-30 | -$1.84M derived: sum of 4 quarters · filed 2014-02-24 |
| 2013-06-30 | -$369.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | -$608.00K 10-Q · filed 2013-08-02 | -$960.00K derived: sum of 3 quarters · filed 2014-02-24 | -$2.21M derived: sum of 4 quarters · filed 2014-02-24 |
| 2013-03-31 | -$239.00K 10-Q · filed 2013-05-13 | -$591.00K derived: sum of 2 quarters · filed 2014-02-24 | -$1.84M derived: sum of 3 quarters · filed 2014-02-24 | -$2.58M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-12-31 | -$352.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | -$1.60M derived: sum of 2 quarters · filed 2014-02-24 | -$2.34M derived: sum of 3 quarters · filed 2014-02-24 | -$3.65M 10-K · filed 2014-02-24 |
| 2012-09-30 | -$1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$1.99M derived: sum of 2 quarters · filed 2013-10-30 | -$3.30M 10-Q · filed 2013-10-30 | -$3.86M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | -$736.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | -$2.05M 10-Q · filed 2013-08-02 | -$2.61M derived: sum of 3 quarters · filed 2014-02-24 | -$2.82M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | -$1.31M 10-Q · filed 2013-05-13 | -$1.87M derived: sum of 2 quarters · filed 2014-02-24 | -$2.09M derived: sum of 3 quarters · filed 2014-02-24 | -$2.14M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | -$559.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | -$772.00K derived: sum of 2 quarters · filed 2014-02-24 | -$826.00K derived: sum of 3 quarters · filed 2014-02-24 | -$897.00K 10-K · filed 2014-02-24 |
| 2011-09-30 | -$213.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-05 | -$267.00K derived: sum of 2 quarters · filed 2012-11-05 | -$338.00K 10-Q · filed 2012-11-05 | -$441.00K derived: sum of 4 quarters · filed 2012-11-05 |
| 2011-06-30 | -$54.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-15 | -$125.00K 10-Q/A · filed 2012-08-15 | -$228.00K derived: sum of 3 quarters · filed 2012-08-15 | -$541.00K derived: sum of 4 quarters · filed 2012-08-15 |
| 2011-03-31 | -$71.00K 10-Q · filed 2012-05-14 | -$174.00K derived: sum of 2 quarters · filed 2012-05-14 | -$487.00K derived: sum of 3 quarters · filed 2012-05-14 | |
| 2010-12-31 | -$103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-12 | -$416.00K derived: sum of 2 quarters · filed 2012-03-12 | -$916.00K 10-K · filed 2012-03-12 | |
| 2010-09-30 | -$313.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-10-25 | -$813.00K 10-Q · filed 2011-10-25 | ||
| 2010-06-30 | -$500.00K 10-Q/A · filed 2011-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |